Hisao Kakegawa

1.2k total citations
39 papers, 1.0k citations indexed

About

Hisao Kakegawa is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hisao Kakegawa has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Hisao Kakegawa's work include Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Natural product bioactivities and synthesis (5 papers). Hisao Kakegawa is often cited by papers focused on Protease and Inhibitor Mechanisms (8 papers), Peptidase Inhibition and Analysis (6 papers) and Natural product bioactivities and synthesis (5 papers). Hisao Kakegawa collaborates with scholars based in Japan, Slovenia and South Korea. Hisao Kakegawa's co-authors include Toshio Satoh, Hitoshi Matsumoto, Nobuhiko Katunuma, Vito Türk, Koji Sumitani, Terushige Kawata, Hiroshi Kamioka, Brigita Lenar≷cic̆, Atsushi Matsui and Yasuo Kishino and has published in prestigious journals such as Biochemical and Biophysical Research Communications, FEBS Letters and Tetrahedron Letters.

In The Last Decade

Hisao Kakegawa

36 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hisao Kakegawa Japan 18 549 225 162 129 121 39 1.0k
Charles S. Schasteen United States 17 430 0.8× 166 0.7× 161 1.0× 104 0.8× 41 0.3× 25 1.1k
Hyeun‐Wook Chang South Korea 23 665 1.2× 173 0.8× 106 0.7× 58 0.4× 88 0.7× 50 1.2k
Elisabeth Dussaulx France 14 755 1.4× 148 0.7× 441 2.7× 111 0.9× 50 0.4× 17 1.5k
Chen‐Kung Chou Taiwan 27 996 1.8× 317 1.4× 231 1.4× 146 1.1× 160 1.3× 51 1.7k
Tomoyuki Tanaka Japan 18 584 1.1× 93 0.4× 247 1.5× 125 1.0× 125 1.0× 46 1.3k
Deepa Nath India 16 592 1.1× 129 0.6× 276 1.7× 105 0.8× 89 0.7× 48 1.3k
Hyun‐Mee Oh South Korea 24 585 1.1× 181 0.8× 202 1.2× 84 0.7× 32 0.3× 55 1.4k
Robert A. R. Hurta Canada 22 821 1.5× 143 0.6× 200 1.2× 198 1.5× 36 0.3× 57 1.4k
Venil N. Sumantran India 20 755 1.4× 153 0.7× 238 1.5× 65 0.5× 52 0.4× 48 1.4k
Min-Nung Huang United States 16 790 1.4× 192 0.9× 446 2.8× 77 0.6× 81 0.7× 30 1.8k

Countries citing papers authored by Hisao Kakegawa

Since Specialization
Citations

This map shows the geographic impact of Hisao Kakegawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisao Kakegawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisao Kakegawa more than expected).

Fields of papers citing papers by Hisao Kakegawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisao Kakegawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisao Kakegawa. The network helps show where Hisao Kakegawa may publish in the future.

Co-authorship network of co-authors of Hisao Kakegawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hisao Kakegawa. A scholar is included among the top collaborators of Hisao Kakegawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisao Kakegawa. Hisao Kakegawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kakegawa, Hisao, et al.. (2004). Significant accumulations of cathepsin B and prolylendopeptidase in inflammatory focus of delayed-type hypersensitivity induced by Mycobacterium tuberculosis in mice. Biochemical and Biophysical Research Communications. 316(1). 78–84. 10 indexed citations
2.
Kihara, Minoru, et al.. (2002). Chondroitin Sulfate Proteoglycan Is a Potent Enhancer in the Processing of Procathepsin L. Biological Chemistry. 383(12). 1925–9. 10 indexed citations
3.
Hashimoto, Yoko, Hisao Kakegawa, Yasushi Narita, et al.. (2001). Significance of Cathepsin B Accumulation in Synovial Fluid of Rheumatoid Arthritis. Biochemical and Biophysical Research Communications. 283(2). 334–339. 94 indexed citations
4.
Katunuma, Nobuhiko, Hisao Kakegawa, Atsushi Matsui, et al.. (1999). Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Letters. 458(1). 6–10. 102 indexed citations
5.
Miyataka, Hideki, et al.. (1999). Inflammatory Action of 8-Methoxypsoralen-Spermine Photoproduct (8-MOP-Spm-PGFC) and Effects of Various Drugs on Rat Paw Edema Induced by 8-MOP-Spm-PGFC.. Biological and Pharmaceutical Bulletin. 22(11). 1202–1206. 1 indexed citations
6.
Katunuma, Nobuhiko, Atsushi Matsui, Hisao Kakegawa, et al.. (1998). Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption. Advances in Enzyme Regulation. 38(1). 235–251. 15 indexed citations
8.
Ohba, Yasuo, Koji Sumitani, Kenji Hiura, et al.. (1996). Inhibitory mechanisms of H+‐ATPase inhibitor bafilomycin A1 and carbonic anhydrase II inhibitor acetazolamide on experimental bone resorption. FEBS Letters. 387(2-3). 175–178. 16 indexed citations
9.
Kakegawa, Hisao, et al.. (1995). Secretion and processing mechanisms of procathepsin L in bone resorption. FEBS Letters. 370(1-2). 78–82. 24 indexed citations
10.
Kakegawa, Hisao, et al.. (1994). Specific Assay Method for the Activities of Cathepsin L-Type Cysteine Proteinases. The Journal of Biochemistry. 116(2). 282–284. 43 indexed citations
11.
Wang, Timothy C., et al.. (1994). Synthesis of 4-Alkoxyaryl .BETA.-D-Glucopyranosides and Their Inhibitory Effects on Histamine Release from Rat Peritoneal Mast Cells Induced by Concanavalin A.. Chemical and Pharmaceutical Bulletin. 42(3). 570–575. 4 indexed citations
12.
Kakegawa, Hisao, et al.. (1993). Inflammatory Activity of Polymeric Photoproducts of Chlorpromazine.. Biological and Pharmaceutical Bulletin. 16(6). 576–578. 2 indexed citations
13.
Kakegawa, Hisao, et al.. (1993). Syntheses and Inhibitory Effects on Gastric Lesions of 4-Guanidinomethylbenzoic Acid Arylamides.. Chemical and Pharmaceutical Bulletin. 41(8). 1387–1390. 1 indexed citations
14.
Kakegawa, Hisao, et al.. (1992). Gastric Cytoprotective Anti-Ulcerogenic Actions of Hydroxychalcones in Rats. Planta Medica. 58(5). 389–393. 47 indexed citations
15.
Kakegawa, Hisao, Hitoshi Matsumoto, & Toshio Satoh. (1992). Inhibitory Effects of Some Natural Products on the Activation of Hyaluronidase and Their Antiallergic Actions.. Chemical and Pharmaceutical Bulletin. 40(6). 1439–1442. 116 indexed citations
16.
Matsumoto, Hitoshi, Yasuhiro Tsuji, Hideki Miyataka, Hisao Kakegawa, & Toshio Satoh. (1989). DDS Using a Ternary System of Drugs, Albumin and Oils (Part. 1) : Increase of Anti-inflammatory Effect and Decrease of Peptic Ulcer of Indomethacin. Journal of Pharmacobio-Dynamics. 12(2).
17.
Matsumoto, Hiromichi, Hisao Kakegawa, & Takahiko Satoh. (1985). Photoactivation of hyaluronidase by chlorpromazine.. PubMed. 2(3). 170–3. 1 indexed citations
18.
Takeda, Yoshio, Tetsuro Fujita, Toshio Satoh, & Hisao Kakegawa. (1985). On the Glycosidic Constituents of Stachys sieboldi MIQ. and Their Effects on Hyarulonidase Activity. YAKUGAKU ZASSHI. 105(10). 955–959. 38 indexed citations
19.
Kakegawa, Hisao, Naoki Mitsuo, Hitoshi Matsumoto, et al.. (1984). STUDIES ON METHODOLOGY OF FINDING THE ANTI-ALLERGIC AGENT WITH THE GUIDANCE OF ANTI-HYALURONIDASE ACTIVITY. Journal of Pharmacobio-Dynamics. 7(5). 2 indexed citations
20.
Kakegawa, Hisao, Hitoshi Matsumoto, & Toshio Satoh. (1984). Inhibitory effect hyaluronidase by non-steroidal antiinflammatory drugs. Ensho. 4(4). 437–438. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026